| KOTAK TAX SAVER
An open-ended equity linked saving scheme with a statutory lock in of 3 years and tax benefits
| KOTAK TAX SAVER
An open-ended equity linked saving scheme with a statutory lock in of 3 years and tax benefits

  

  
Investment Objective
The investment objective of the scheme is to generate long-term capital appreciation from a diversified portfolio of equity and equity related securities and enable investors to avail the income tax rebate, as permitted from time to time however, there is no assurance that the objective of the scheme will be realized.
The investment objective of the scheme is to generate long-term capital appreciation from a diversified portfolio of equity and equity related securities and enable investors to avail the income tax rebate, as permitted from time to time however, there is no assurance that the objective of the scheme will be realized.
Issuer/Instrument Industry/
Rating
% to Net
Assets

Equity & Equity related
Banks 23.98
ICICI Bank Ltd. 7.71
State Bank Of India 5.62
Axis Bank Ltd. 5.32
HDFC Bank Ltd. 2.20
Bank Of Baroda 1.69
AU Small Finance Bank Ltd. 1.44
IT - Software 6.33
Infosys Ltd. 4.02
Tata Consultancy Services Ltd. 2.31
Chemicals & Petrochemicals 6.16
SRF Ltd. 3.01
Linde India Ltd. 2.01
Solar Industries India Limited 0.96
Tata Chemicals Ltd 0.18
Consumer Durables 5.71
Whirlpool of India Ltd. 1.34
Kansai Nerolac Paints Ltd 1.11
Blue Star Ltd. 1.03
V-Guard Industries Ltd. 0.72
Sheela Foam Ltd 0.68
Bata India Ltd. 0.45
Hawkins Cooker Ltd 0.38
Automobiles 5.62
Maruti Suzuki India Limited 2.80
Mahindra & Mahindra Ltd. 1.98
Bajaj Auto Ltd. 0.84
Construction 5.42
Larsen And Toubro Ltd. 3.80
JMC Projects (India) Ltd. 0.64
Kalpataru Power Transmission Ltd. 0.62
Ashoka Buildcon Limited 0.36
Industrial Products 5.05
Cummins India Ltd. 1.87
SKF India Ltd 1.12
Bharat Forge Ltd. 1.09
Carborundum Universal Ltd. 0.97
Diversified FMCG 4.99
ITC Ltd. 3.53
Hindustan Unilever Ltd. 1.46
Pharmaceuticals & Biotechnology 4.37
Sun Pharmaceuticals Industries Ltd. 2.32
Cipla Ltd. 1.14
Zydus Lifesciences Limited 0.91
Petroleum Products 4.16
Reliance Industries Ltd. 4.16
Cement & Cement Products 3.88
Ambuja Cements Ltd. 2.45
Ultratech Cement Ltd. 1.43
Electrical Equipment 3.52
ABB India Ltd 1.89
Thermax Ltd. 1.63
Finance 3.05
Bajaj Finance Ltd. 2.22
Bajaj Finserv Ltd. 0.83
Ferrous Metals 2.03
Jindal Steel & Power Ltd. 2.03
Telecom - Services 1.99
Bharti Airtel Ltd 1.94
Bharti Airtel Ltd - Partly Paid Shares 0.05
Beverages 1.98
United Spirits Ltd. 1.98
Transport Services 1.90
Blue Dart Express Ltd. 0.99
Container Corporation of India Ltd. 0.91
Fertilizers & Agrochemicals 1.65
Coromandel International Ltd. 1.65
Power 1.24
National Thermal Power Corporation Limited 1.24
Agricultural, Commercial & Construction Vehicles 1.00
Ashok Leyland Ltd. 1.00
Agricultural Food & other Products 0.88
Balrampur Chini Mills Ltd. 0.88
Auto Components 0.87
Balkrishna Industries Ltd. 0.87
Gas 0.79
Gujarat State Petronet Ltd. 0.79
Non - Ferrous Metals 0.79
Hindalco Industries Ltd 0.79
Insurance 0.46
Max Financial Services Ltd. 0.46
Capital Markets 0.30
Prudent Corporate Advisory Services Ltd. 0.30
Equity & Equity related - Total 98.12
Triparty Repo 1.99
Net Current Assets/(Liabilities) -0.11
Grand Total 100.00

Systematic Investment Plan (SIP) If you had invested Rs 10,000 every month
Monthly SIP of (₹) 10000 Since Inception 10 years 7 years 5 years 3 years 1 year
Total amount invested (₹) 20,40,000 12,00,000 8,40,000 6,00,000 3,60,000 1,20,000
Total Value as on Oct 31, 2022 (₹)70,84,251 27,08,235 14,79,471 9,33,873 4,99,833 1,28,901
Scheme Returns (%) 13.27 15.54 15.89 17.74 22.54 14.06
Nifty 500 (TRI) Returns (%) 13.02 14.66 15.45 16.83 21.97 10.51
Alpha 0.24 0.88 0.44 0.91 0.56 3.55
Nifty 500 (TRI) (₹)# 69,13,681 25,82,894 14,56,621 9,13,334 4,95,959 1,26,687
Nifty 50 (TRI) (₹)^ 66,57,070 24,98,869 14,46,264 9,00,866 4,85,108 1,27,080
Nifty 50 (TRI) Returns (%)12.64 14.04 15.25 16.27 20.38 11.14

Scheme Inception : - November 23, 2005. The returns are calculated by XIRR approach assuming investment of Rs10,000/- on the 1st working day of every month. XIRR helps in calculating return on investments given an initial and final value and a series of cash inflows and outflows and taking the time of investment into consideration. Since inception returns are assumed to be starting from the beginning of the subsequent month from the date of inception. # Benchmark ; ^ Additional Benchmark. TRI – Total Return Index, In terms of SEBI circular dated January 4, 2018, the performance of the scheme is benchmarked to the Total Return variant (TRI) of the Benchmark Index instead of Price Return Variant (PRI). Alpha is difference of scheme return with benchmark return. *All payouts during the period have been reinvested in the units of the scheme at the then prevailing NAV. Returns >= 1 year: CAGR (Compounded Annualised Growth Rate). N.A stands for data not available. Note: Point to Point (PTP) Returns in INR shows the value of 10,000/- investment made at inception. Source: ICRA MFI Explorer.
NAV
Reg-Plan-IDCW Rs28.487
Dir-Plan-IDCW Rs36.134
Growth optionRs76.119
Direct Growth optionRs86.26

Available Plans/Options

A) Regular Plan B) Direct Plan
Options: Growth and IDCW (Payout) (applicable for all plans)


Fund Manager* Mr. Harsha Upadhyaya
BenchmarkNifty 500 TRI
Allotment dateNovember 23, 2005
AAUMRs2,966.23 crs
AUMRs3,062.89 crs
Folio count3,48,531

IDCW Frequency

Trustee's Discretion


Ratios
Portfolio Turnover14.04%
$Beta0.92
$Sharpe ##0.64
$Standard Deviation21.21%
(P/E) 23.5
P/BV 3.4
IDCW Yield 0.9
Source: $ ICRA MFI Explorer.

Minimum Investment Amount

Initial Investment: Rs500 and in multiple of Rs500
Additional Investment: Rs500 & in multiples of Rs500
Ideal Investments Horizon: 5 years & above


Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load: Nil. (applicable for all plans)


Total Expense Ratio**

Regular: 1.97%; Direct: 0.68%


Data as on October 31, 2022

Fund


Benchmark
This product is suitable for investors who are seeking*:
  • long term capital growth with a 3 year lock in
  • Investment in portfolio of predominantly equity & equity related securities.

* Investors should consult their financial advisers if in doubt about whether the product is suitable for them.



## Risk rate assumed to be 6.25% (FBIL Overnight MIBOR rate as on 31st October 2022).**Total Expense Ratio includes applicable B30 fee and GST.
* For Fund Manager experience, please refer 'Our Fund Managers'
For last three IDCW, please refer 'Dividend History'.
For scheme performance, please refer 'Scheme Performances'